Fresenius SE Other Non-Current Liabilities 2016-2024 | FSNUY

Fresenius SE other non-current liabilities from 2016 to 2024. Other non-current liabilities can be defined as field containing the sum of all non-current liabilities that cannot be standardized into another field as well as those that are aggregated by the company because materially, they are too small to list separately.
  • Fresenius SE other non-current liabilities for the quarter ending June 30, 2024 were $1.222B, a 62.1% decline year-over-year.
  • Fresenius SE other non-current liabilities for 2023 were $2.01B, a 37.33% decline from 2022.
  • Fresenius SE other non-current liabilities for 2022 were $3.207B, a 40.75% increase from 2021.
  • Fresenius SE other non-current liabilities for 2021 were $2.279B, a 9% decline from 2020.
Fresenius SE Annual Other Non-Current Liabilities
(Millions of US $)
2023 $2,010
2022 $3,207
2021 $2,279
2020 $2,504
2019 $2,076
2018 $2,198
2017 $2,636
2016 $1,578
2015 $1,306
Fresenius SE Quarterly Other Non-Current Liabilities
(Millions of US $)
2024-06-30 $1,222
2024-03-31 $2,031
2023-12-31 $2,010
2023-09-30 $1,948
2023-06-30 $3,225
2023-03-31 $261
2022-12-31 $3,207
2022-09-30 $3,083
2022-06-30 $2,315
2022-03-31 $1,865
2021-12-31 $2,279
2021-09-30 $4,193
2021-06-30 $347
2021-03-31 $2,498
2020-12-31 $2,504
2020-09-30 $2,259
2020-06-30 $2,113
2020-03-31 $2,023
2019-12-31 $2,076
2019-09-30 $2,048
2019-06-30 $2,127
2019-03-31 $2,113
2018-12-31 $2,198
2018-09-30 $2,361
2018-06-30 $2,608
2018-03-31 $2,659
2017-12-31 $2,636
2017-09-30 $2,788
2017-06-30 $2,084
2017-03-31 $2,120
2016-12-31 $1,578
2016-09-30 $1,371
2016-06-30 $1,358
2016-03-31 $1,272
2015-12-31 $2,503
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $19.458B $24.011B
Fresenius SE & Co is a health care company. It offers products and services for dialysis, hospitals and outpatient treatment. The company's business segment consists of Fresenius Medical Care is engaged in treating with chronic kidney failure; Fresenius Helios is a hospital operator; Fresenius Kabi supplies essential drugs, clinical nutrition products, medical devices and services and Fresenius Vamed plans, develops and manages healthcare facilities. Fresenius SE & Co is headquartered in Bad Homburg, Germany.
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $17.988B 18.23
DaVita (DVA) United States $12.872B 16.65
Encompass Health (EHC) United States $9.984B 23.54
Chemed (CHE) United States $8.238B 25.32
Elanco Animal Health (ELAN) United States $6.580B 15.66
RadNet (RDNT) United States $5.911B 130.90
Option Care Health (OPCH) United States $3.713B 17.60
Amedisys (AMED) United States $2.948B 20.98
LifeStance Health (LFST) United States $2.770B 0.00
Astrana Health (ASTH) United States $2.302B 31.49
Addus HomeCare (ADUS) United States $2.180B 25.57
U.S Physical Therapy (USPH) United States $1.368B 35.96
Aveanna Healthcare Holdings (AVAH) United States $1.121B 0.00
Pennant (PNTG) United States $1.093B 44.18
Atai Life Sciences (ATAI) Germany $0.290B 0.00
Daxor (DXR) United States $0.043B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.015B 0.00
Psychemedics (PMD) United States $0.014B 0.00
ATI Physical Therapy (ATIP) United States $0.008B 0.00
Ontrak (OTRK) United States $0.008B 0.00
IMAC Holdings (BACK) United States $0.001B 0.00